2269 articles by Nick Paul Taylor
-
FDA labels Cue’s recall of COVID tests as Class II, revokes EUAs
Oct. 17, 2024 -
Health officials outline industry role in AI oversight in JAMA article
Oct. 16, 2024 -
Hologic to buy Gynesonics for $350M to acquire fibroid system
Oct. 15, 2024 -
J&J, Abbott and Intuitive kick off latest medtech earnings season
Oct. 14, 2024 -
Abbott enrolls pivotal PFA study 4 months ahead of schedule
Oct. 11, 2024 -
Shiratronics raises $66M for trial of neuromodulation migraine device
Oct. 10, 2024 -
Procept secures FDA approval to study surgical robot in prostate cancer
Oct. 9, 2024 -
Mercury Medical recalls emergency resuscitators
Oct. 8, 2024 -
Exact Sciences wins FDA approval for Cologuard Plus colorectal cancer test
Oct. 7, 2024 -
Elucid wins FDA 510(k) nod for heart plaque image analysis software
Oct. 4, 2024 -
FDA authorizes Pi-Cardia’s valve-in-valve TAVR device
Oct. 3, 2024 -
Siemens Healthineers wins FDA approval for 3D mammography system
Oct. 2, 2024 -
Synchron’s brain-computer interface tech meets safety goal
Oct. 1, 2024 -
Establishment Labs wins FDA approval for Motiva breast implants
Sept. 30, 2024 -
Mendaera raises $73M to develop handheld robotics platform
Sept. 27, 2024 -
FDA proposes reclassifying hepatitis B assays
Sept. 26, 2024 -
Roche launches test that detects 12 respiratory viruses
Sept. 25, 2024 -
Route 92 Medical raises $50M to fund global sales of stroke devices
Sept. 24, 2024 -
Stryker adds devices to remove brain tumors, clots with Nico buy
Sept. 23, 2024 -
FDA posts draft guidance on biocompatibility testing of devices
Sept. 23, 2024 -
GE Healthcare wins FDA clearance for Alzheimer’s imaging software
Sept. 20, 2024 -
Merit Medical inks $210M takeover of Cook’s lead management business
Sept. 18, 2024 -
Synchron connects brain-computer interface tech to Amazon Alexa
Sept. 17, 2024 -
Advamed backs FDA’s misinformation draft, calls for updates on AI and deep fakes
Sept. 16, 2024 -
Apple wins FDA nod for hearing aid software for certain Airpods
Sept. 13, 2024